Publications

Unwin, H. et al. (2020) “State-level tracking of COVID-19 in the United States”, Nature Communications, 11(1), p. 6189.

Riley, S. et al. (2020) “REACT-1 round 7 interim report: fall in prevalence of swab-positivity in England during national lockdown”, p. 2020.11.30.20239806.

Grassly, N. et al. (2020) “Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study”, The Lancet Infectious Diseases, 20(12), pp. 1381–1389.

Dighe, A. et al. (2020) “Response to COVID-19 in South Korea and implications for lifting stringent interventions”, BMC Medicine, 18(1), p. 321.

Watson, J. and Holmes, C. (2020) “Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error”, Trials, 21(1), p. 156.

Watson, J. and Holmes, C. (2020) “Correction to: Graphing and reporting heterogeneous treatment effects through reference classes”, Trials, 21(1), p. 865.

Kendall, M. et al. (2020) “Epidemiological changes on the Isle of Wight after the launch of the NHS Test and Trace programme: a preliminary analysis”, The Lancet Digital Health, 2(12), pp. e658 - e666.

Watson, J. and Holmes, C. (2020) “Graphing and reporting heterogeneous treatment effects through reference classes”, Trials, 21(1), p. 386.

Parag, K. et al. (2020) “An exact method for quantifying the reliability of end-of-epidemic declarations in real time”, PLOS Computational Biology, 16(11), p. e1008478.

Parag, K., Cowling, B. and Donnelly, C. (2020) “Deciphering early-warning signals of SARS-CoV-2 elimination and resurgence from limited data at multiple scales”, p. 2020.11.23.20236968.